- Home
- ANNX vs TWFG Comparison
ANNX vs TWFG Comparison
Compare ANNX & TWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- TWFG
- Stock Information
- Founded
- ANNX 2011
- TWFG 2001
- Country
- ANNX United States
- TWFG United States
- Employees
- ANNX N/A
- TWFG N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- TWFG
- Sector
- ANNX Health Care
- TWFG
- Exchange
- ANNX Nasdaq
- TWFG NYSE
- Market Cap
- ANNX 553.2M
- TWFG 484.1M
- IPO Year
- ANNX 2020
- TWFG 2024
- Fundamental
- Price
- ANNX $4.20
- TWFG $30.70
- Analyst Decision
- ANNX Strong Buy
- TWFG Buy
- Analyst Count
- ANNX 7
- TWFG 8
- Target Price
- ANNX $15.80
- TWFG $31.86
- AVG Volume (30 Days)
- ANNX 1.5M
- TWFG 151.6K
- Earning Date
- ANNX 11-14-2024
- TWFG 02-15-2025
- Dividend Yield
- ANNX N/A
- TWFG N/A
- EPS Growth
- ANNX N/A
- TWFG N/A
- EPS
- ANNX N/A
- TWFG 0.43
- Revenue
- ANNX N/A
- TWFG $194,211,000.00
- Revenue This Year
- ANNX N/A
- TWFG $19.28
- Revenue Next Year
- ANNX N/A
- TWFG $19.53
- P/E Ratio
- ANNX N/A
- TWFG $71.40
- Revenue Growth
- ANNX N/A
- TWFG 26.18
- 52 Week Low
- ANNX $3.86
- TWFG $21.31
- 52 Week High
- ANNX $8.40
- TWFG $36.50
- Technical
- Relative Strength Index (RSI)
- ANNX 31.21
- TWFG N/A
- Support Level
- ANNX $4.53
- TWFG N/A
- Resistance Level
- ANNX $4.99
- TWFG N/A
- Average True Range (ATR)
- ANNX 0.31
- TWFG 0.00
- MACD
- ANNX -0.08
- TWFG 0.00
- Stochastic Oscillator
- ANNX 14.07
- TWFG 0.00
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.